arrow
P

Philippe Rochaix

oncopole
H指数:45
被引数:6,216

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Myxoid neoplasms with MAP3K kinase fusion: a study of 39 cases

黏液样肿瘤伴MAP3K激酶融合:39例研究

2026-08-190
PRE
MiT fusions, TSC1–TSC2 divergence, and stem-like programs reveal distinct origins and vulnerabilities in PEComa

MiT融合、TSC1–TSC2分化以及干细胞样程序揭示PEComa的不同起源和脆弱性

2026-06-230
OAAI
Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy

林奇综合征患者中发生的肉瘤富集于多形性软组织肉瘤,并且对免疫疗法敏感。

2025-02-011
PRE
Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcome
2021-12-062
OAAI
Exploratory window-of-opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer
2021-11-1117
OAAI
PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells
2021-01-2589
OA
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
2020-01-23107
OAAI
Open-label, non-randomized, exploratory pre-operative window-of-opportunity trial to investigate the pharmacokinetics and pharmacodynamics of the smac mimetic Debio 1143 in patients with resectable squamous cell carcinoma of the head and neck
2019-07-015
PRE